22 January, 2021

Your Crocin And Betadine May Be Spurious -- Counterfeit Drugs Market Leaves Regulators In A Spin

Absence of a scientific investigation model is a major reason to estimate the extent of substandard drugs in the country

Your Crocin And Betadine May Be Spurious -- Counterfeit Drugs Market Leaves Regulators In A Spin
outlookindia.com
2019-10-12T11:17:30+05:30

Government-sponsored studies—thrice in over 15 years—show just three per cent of medicines in the Indian market are of substandard quality or counterfeit. But various reports, which Outlook couldn’t verify, peg this figure between 25 and 40 per cent. In a 2015 report, ASSOCHAM said 25 per cent of medicines sold in India are either fake or of inferior quality, the majority counterfeiting popular over-the-counter drugs sold under generic names such as Crocin and Betadine. “Any study showing a higher percentage of Indian drugs as substandard or fake serves the interest of foreign pharma companies since Indian companies have always posed them a threat,” says former International Pharmaceutical Federation vice president Prafull D. Shah, who played a key role in the most recent drug sample survey in 2018. Shah says he had asked ASSOCHAM for the data based on which it arrived at the 25 per cent figure, but “they never provided it”.

In 2003, the BJP government had for the first time appointed an expert committee under the...

unsub

THIS ARTICLE IS PRICELESS...

To read this piece, and more such stories in India's most exciting and exacting magazine, plus get access to our 25-year archives goldmine, please subscribe.


More from Jeevan Prakash Sharma


Latest Magazine

February 01, 2021
content

other articles from the issue

articles from the previous issue

Other magazine section